Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.



<ul>
<li>Evercore ISI Group analyst Amit Daryanani initiated coverage on SanDisk Corp (NASDAQ:SNDK) with an Outperform rating and announced a price target of $1,200. SanDisk shares closed at $952.50 on Monday. See how other analysts view this stock.</li>



<li>Morgan Stanley analyst Ronald Kamdem initiated coverage on Janus Living Inc (NYSE:JAN) with an Overweight rating and announced a price target of $28. Janus Living shares closed at $23.99 on Monday. See how other analysts view this stock.</li>



<li>Piper Sandler analyst Matt O’Brien initiated coverage on Adagio Medical Holdings Inc (NASDAQ:ADGM) with an Overweight rating and announced a price target of $3. Adagio Medical shares closed at $1.33 on Monday. See how other analysts view this stock.</li>



<li>Raymond James analyst Martin Auster initiated coverage on Spyre Therapeutics Inc (NASDAQ:SYRE) with a Strong Buy rating and announced a price target of $80. Spyre Therapeutics shares closed at $63.27 on Monday. See how other analysts view this stock.</li>



<li>Evercore ISI Group analyst Peter Levine initiated coverage on Fastly Inc (NASDAQ:FSLY) with an Outperform rating and announced a price target of $32. Fastly shares closed at $24.37 on Monday. See how other analysts view this stock.</li>
</ul>



Considering buying SNDK stock? Here’s what analysts think: 



<figure class="wp-block-image size-large is-resized"></figure>



Photo via Shutterstock

SNDK

FSLY

Top Wall Street analysts have initiated coverage on several companies with bullish ratings. Evercore ISI's Amit Daryanani rated SanDisk Corp (SNDK) as Outperform with a price target of $1,200. Morgan Stanley's Ronald Kamdem rated Janus Living Inc (JAN) Overweight with a target of $28. Piper Sandler's Matt O’Brien rated Adagio Medical Holdings Inc (ADGM) Overweight with a target of $3. Raymond James' Martin Auster rated Spyre Therapeutics Inc (SYRE) Strong Buy with a target of $80. Evercore's Peter Levine rated Fastly Inc (FSLY) Outperform with a target of $32.

- Top Wall Street analysts have recently altered their outlooks on several stocks.  
- Analyst Amit Daryanani rates SanDisk Corp (SNDK) as Outperform with a target of $1,200, while Ronald Kamdem gives Janus Living Inc (JAN) an Overweight rating of $28.  
- Other analysts have shared similar views on Adagio Medical Holdings Inc (ADGM) and Spyre Therapeutics Inc (SYRE), with respective target prices of $3 and $80.

benzinga_article

Janus Living

Sandisk

Fastly

Adagio Medical

Spyre Therapeutics

SPDR S&P Health Equip

iShares Semiconductor ETF

First Trust Nasdaq Food & Semicon

Direxion Semicon Bull 3X

Invesco PHLX Semiconductor ETF

Invesco Biotechnology & Genome ETF

SPDR S&P Semicon

VanEck Biotech ETF

Invesco Semiconductors ETF

First Trust NYSE Arca Biotech Index Fd

VanEck Semiconductor ETF

Direxion S&P Biotech Bull 3X

iShares Biotechnology ETF

ALPS Medical Breakthrough

SPDR S&P Biotech

iShares US Medical Devices

Evercore

Morgan Stanley

Piper Sandler Cos

Raymond James Financial

Sandisk - WI

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

RAYMOND JAMES FINANCIAL INC 6.375%DEP SHS REP 1/40TH FXD FLTG SER B

This SanDisk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday